vs
Side-by-side financial comparison of KAMADA LTD (KMDA) and NIP Group Inc. (NIPG). Click either name above to swap in a different company.
KAMADA LTD is the larger business by last-quarter revenue ($47.0M vs $39.3M, roughly 1.2× NIP Group Inc.). KAMADA LTD runs the higher net margin — 11.3% vs -11.9%, a 23.1% gap on every dollar of revenue.
Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.
KMDA vs NIPG — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $47.0M | $39.3M |
| Net Profit | $5.3M | $-4.7M |
| Gross Margin | 42.0% | 6.0% |
| Operating Margin | 16.6% | -13.0% |
| Net Margin | 11.3% | -11.9% |
| Revenue YoY | 12.6% | — |
| Net Profit YoY | 37.1% | — |
| EPS (diluted) | $0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $47.0M | — | ||
| Q2 25 | $44.8M | — | ||
| Q1 25 | $44.0M | — | ||
| Q3 24 | $41.7M | — | ||
| Q2 24 | $42.5M | $39.3M | ||
| Q1 24 | $37.7M | — | ||
| Q3 23 | $37.9M | — | ||
| Q2 23 | $37.4M | — |
| Q3 25 | $5.3M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $4.0M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $4.4M | $-4.7M | ||
| Q1 24 | $2.4M | — | ||
| Q3 23 | $3.2M | — | ||
| Q2 23 | $1.8M | — |
| Q3 25 | 42.0% | — | ||
| Q2 25 | 42.3% | — | ||
| Q1 25 | 47.1% | — | ||
| Q3 24 | 41.3% | — | ||
| Q2 24 | 44.6% | 6.0% | ||
| Q1 24 | 44.4% | — | ||
| Q3 23 | 39.0% | — | ||
| Q2 23 | 38.6% | — |
| Q3 25 | 16.6% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 17.7% | — | ||
| Q3 24 | 12.7% | — | ||
| Q2 24 | 13.3% | -13.0% | ||
| Q1 24 | 10.7% | — | ||
| Q3 23 | 11.5% | — | ||
| Q2 23 | 7.0% | — |
| Q3 25 | 11.3% | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 9.0% | — | ||
| Q3 24 | 9.3% | — | ||
| Q2 24 | 10.4% | -11.9% | ||
| Q1 24 | 6.3% | — | ||
| Q3 23 | 8.5% | — | ||
| Q2 23 | 4.8% | — |
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.13 | — | ||
| Q1 25 | $0.07 | — | ||
| Q3 24 | $0.07 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $0.04 | — | ||
| Q3 23 | $0.06 | — | ||
| Q2 23 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.0M | $6.8M |
| Total DebtLower is stronger | — | $3.8M |
| Stockholders' EquityBook value | $265.2M | — |
| Total Assets | $377.2M | $305.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $72.0M | — | ||
| Q2 25 | $66.0M | — | ||
| Q1 25 | $76.3M | — | ||
| Q3 24 | $72.0M | — | ||
| Q2 24 | $56.5M | $6.8M | ||
| Q1 24 | $48.2M | — | ||
| Q3 23 | $52.6M | — | ||
| Q2 23 | $21.8M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $3.8M | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | $265.2M | — | ||
| Q2 25 | $260.0M | — | ||
| Q1 25 | $252.0M | — | ||
| Q3 24 | $255.3M | — | ||
| Q2 24 | $251.2M | — | ||
| Q1 24 | $251.2M | — | ||
| Q3 23 | $238.4M | — | ||
| Q2 23 | $176.8M | — |
| Q3 25 | $377.2M | — | ||
| Q2 25 | $368.2M | — | ||
| Q1 25 | $375.1M | — | ||
| Q3 24 | $351.2M | — | ||
| Q2 24 | $351.0M | $305.3M | ||
| Q1 24 | $343.2M | — | ||
| Q3 23 | $337.1M | — | ||
| Q2 23 | $314.4M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.4M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.97× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $10.4M | — | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $-513.0K | — | ||
| Q3 24 | $22.2M | — | ||
| Q2 24 | $14.0M | — | ||
| Q1 24 | $1.0M | — | ||
| Q3 23 | $921.0K | — | ||
| Q2 23 | $1.8M | — |
| Q3 25 | 1.97× | — | ||
| Q2 25 | 1.09× | — | ||
| Q1 25 | -0.13× | — | ||
| Q3 24 | 5.75× | — | ||
| Q2 24 | 3.15× | — | ||
| Q1 24 | 0.43× | — | ||
| Q3 23 | 0.29× | — | ||
| Q2 23 | 1.00× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
